Van den Bosch FE - Search Results

1

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.

Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J. Kiltz U, et al. Among authors: van der heijde d, van tubergen a, van den bosch fe. Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun 1. Ann Rheum Dis. 2018. PMID: 29858176 Free article.

2

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

Van den Bosch F, Kruithof E, Baeten D, De Keyser F, Mielants H, Veys EM. Van den Bosch F, et al. Ann Rheum Dis. 2000 Jun;59(6):428-33. doi: 10.1136/ard.59.6.428. Ann Rheum Dis. 2000. PMID: 10834859 Free PMC article.

3

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.

Baeten D, Van Damme N, Van den Bosch F, Kruithof E, De Vos M, Mielants H, Veys EM, De Keyser F. Baeten D, et al. Ann Rheum Dis. 2001 Aug;60(8):750-5. doi: 10.1136/ard.60.8.750. Ann Rheum Dis. 2001. PMID: 11454638 Free PMC article.

4

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

Baeten D, Kruithof E, Van den Bosch F, Van den Bossche N, Herssens A, Mielants H, De Keyser F, Veys EM. Baeten D, et al. Ann Rheum Dis. 2003 Sep;62(9):829-34. doi: 10.1136/ard.62.9.829. Ann Rheum Dis. 2003. PMID: 12922954 Free PMC article.

5

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.

De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F. De Rycke L, et al. Ann Rheum Dis. 2005 Feb;64(2):299-302. doi: 10.1136/ard.2004.023523. Epub 2004 May 27. Ann Rheum Dis. 2005. PMID: 15166003 Free PMC article.

6

Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy.

Kruithof E, Baeten D, Van den Bosch F, Mielants H, Veys EM, De Keyser F. Kruithof E, et al. Ann Rheum Dis. 2005 Apr;64(4):529-36. doi: 10.1136/ard.2003.018549. Epub 2004 Sep 23. Ann Rheum Dis. 2005. PMID: 15388510 Free PMC article. Clinical Trial.

7

Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.

Vandooren B, Kruithof E, Yu DT, Rihl M, Gu J, De Rycke L, Van Den Bosch F, Veys EM, De Keyser F, Baeten D. Vandooren B, et al. Arthritis Rheum. 2004 Sep;50(9):2942-53. doi: 10.1002/art.20477. Arthritis Rheum. 2004. PMID: 15457463 Free article.

8

Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial.

van der Heijde D, Han C, DeVlam K, Burmester G, van den Bosch F, Williamson P, Bala M, Han J, Braun J. van der Heijde D, et al. Arthritis Rheum. 2006 Aug 15;55(4):569-74. doi: 10.1002/art.22097. Arthritis Rheum. 2006. PMID: 16874778 Free article. Clinical Trial.

9

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.

Vander Cruyssen B, Ribbens C, Boonen A, Mielants H, de Vlam K, Lenaerts J, Steinfeld S, Van den Bosch F, Dewulf L, Vastesaeger N. Vander Cruyssen B, et al. Ann Rheum Dis. 2007 Aug;66(8):1072-7. doi: 10.1136/ard.2006.064543. Epub 2007 Jan 29. Ann Rheum Dis. 2007. PMID: 17261531 Free PMC article.

10

Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis.

Van Beneden K, Coppieters K, Laroy W, De Keyser F, Hoffman IE, Van den Bosch F, Vander Cruyssen B, Drennan M, Jacques P, Rottiers P, Verbruggen G, Contreras R, Callewaert N, Elewaut D. Van Beneden K, et al. Ann Rheum Dis. 2009 Aug;68(8):1360-5. doi: 10.1136/ard.2008.089292. Epub 2008 Sep 4. Ann Rheum Dis. 2009. PMID: 18772190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page